Market Tracker

09/27 7:56am ET

Puma Biotechnology Inc (NYSE:PBYI)

69.68
Delayed Data
As of Sep 26
 +1.60 / +2.35%
Today’s Change
19.74
Today|||52-Week Range
94.93
-11.12%
Year-to-Date
Puma Biotechnology Shares Leap Forward
Sep 22 / TheStreet.com - Paid Partner Content
Forget Sarepta Therapeutics, Here Are 3 Other Biotech Stocks to Buy
Sep 20 / MotleyFool.com - Paid Partner Content
Puma (PBYI) Neratinib's NDA Accepted for Review, Stock Up
Sep 21 / Zacks.com - Paid Partner Content
Why Puma Biotechnology Inc Roared Higher Today
Sep 20 / MotleyFool.com - Paid Partner Content
3 Clinical-Stage Biotechs to Buy Ahead of FDA Decisions
Sep 21 / MotleyFool.com - Paid Partner Content
Why Puma Biotechnology (PBYI) Stock Is Surging Today
Sep 20 / TheStreet.com - Paid Partner Content
Puma Biotechnology (PBYI) Shares March Higher, Can It Continue?
Sep 21 / Zacks.com - Paid Partner Content
Puma Biotechnology (PBYI): Moving Average Crossover Alert
Sep 13 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close68.08
Today’s open67.29
Day’s range67.29 - 69.95
Volume911,165
Average volume (3 months)774,626
Market cap$2.2B
Dividend yield--
Data as of 09/26/2016

Growth & Valuation

Earnings growth (last year)-57.51%
Earnings growth (this year)-4.56%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book10.73

Competitors

 Today’s
change
Today’s
% change
AGIOAgios Pharmaceutical...-0.33-0.62%
PRTAProthena Corporation...-0.54-0.86%
IRWDIronwood Pharmaceuti...-0.21-1.34%
OPHTOphthotech Corp-0.58-1.00%
Data as of 09/26/2016

Financials

Next reporting dateNovember 7, 2016
EPS forecast (this quarter)-$1.96
Annual revenue (last year)$0.00
Annual profit (last year)-$239.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President, CEO &
Secretary
Alan H. Auerbach
Treasurer &
Senior VP-Finance & Administration
Charles R. Eyler
Corporate headquarters
Los Angeles, California

Forecasts